LHC
TMO icon

Little House Capital’s Thermo Fisher Scientific TMO Stock Holding History

Little House Capital’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,991
Closed -$1.04M – 150
2024
Q4 		$1.04M Sell
1,991
-230
-10% -$126K 0.3% 67
2024
Q3 		$1.37M Buy
2,221
+15
+0.7% +$8.88K 0.39% 60
2024
Q2 		$1.22M Buy
2,206
+82
+4% +$47K 0.38% 62
2024
Q1 		$1.23M Sell
2,124
-2,466
-54% -$1.38M 0.41% 60
2023
Q4 		$2.44M Buy
4,590
+127
+3% +$61.5K 0.89% 33
2023
Q3 		$2.26M Buy
4,463
+502
+13% +$268K 0.93% 29
2023
Q2 		$2.07M Buy
3,961
+513
+15% +$277K 0.88% 32
2023
Q1 		$1.99M Sell
3,448
-237
-6% -$134K 0.94% 32
2022
Q4 		$2.03M Sell
3,685
-4
-0.1% -$2.12K 1% 34
2022
Q3 		$1.87M Buy
3,689
+399
+12% +$223K 1% 30
2022
Q2 		$1.79M Buy
3,290
+808
+33% +$445K 0.96% 32
2022
Q1 		$1.47M Buy
2,482
+797
+47% +$458K 0.75% 46
2021
Q4 		$1.12M Buy
1,685
+117
+7% +$73K 0.59% 53
2021
Q3 		$896K Sell
1,568
-82
-5% -$45K 0.53% 60
2021
Q2 		$832K Buy
+1,650
New +$779K 0.45% 68
2021
Q1 		– Sell
-1,715
Closed -$798K – 159
2020
Q4 		$798K Sell
1,715
-30
-2% -$14.1K 0.59% 54
2020
Q3 		$770K Sell
1,745
-225
-11% -$93K 0.64% 55
2020
Q2 		$713K Buy
1,970
+22
+1% +$7.37K 0.66% 53
2020
Q1 		$552K Buy
1,948
+20
+1% +$6.31K 0.6% 50
2019
Q4 		$627K Sell
1,928
-30
-2% -$9.1K 0.54% 58
2019
Q3 		$571K Sell
1,958
-156
-7% -$44.7K 0.43% 72
2019
Q2 		$621 Sell
2,114
-68
-3% -$18.7K 0.41% 69
2019
Q1 		$597K Sell
2,182
-267
-11% -$66.4K 0.45% 70
2018
Q4 		$549K Buy
+2,449
New +$575K 0.53% 68

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Little House Capital's TMO Position: Q1 2025 in Review

Little House Capital sold out of Thermo Fisher Scientific (TMO) in Q1 2025, closing a stake of 1,991 shares — an estimated $1.04M sold.

Little House Capital first reported a position in TMO in Q4 2018 and held it in 24 quarters. The position peaked at $2.44M in Q4 2023. 2,570 funds tracked by Wall St. Rank hold TMO as of Q1 2025.

  • Little House Capital reported no remaining Thermo Fisher Scientific position as of Q1 2025 after selling out during the quarter.
  • Little House Capital sold 1,991 Thermo Fisher Scientific shares in Q1 2025, an estimated $1.04M.
  • Little House Capital first reported a position in Thermo Fisher Scientific in Q4 2018 and held it in 24 quarters.
  • Little House Capital's Thermo Fisher Scientific position peaked at $2.44M in Q4 2023.
  • 2,570 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2025.

Based on Little House Capital's 13F filing for Q1 2025, filed 25 Apr 2025.